Table 7 Total treatment costs for with and without SEB scenarios in year 4
Patient type (CKD stage) | Treatments for anemia | Year 4 Total costs ($) | |
|---|---|---|---|
Without SEB | With SEB | ||
Stage III/IV | Short acting ESA (SC) | 38,308,544 | 25,996,178 |
Long acting ESA (SC) | 39,849,400 | 27,041,803 | |
Epoetin SEB | - | 13,411,903 | |
Stage V | Short acting ESA (SC) | 29,148,598 | 19,780,239 |
Long acting ESA (SC) | 20,185,070 | 13,697,588 | |
Short acting ESA (IV) | 119,750,354 | 81,262,590 | |
Long acting ESA (IV) | 83,272,569 | 56,508,765 | |
Epoetin SEB | - | 43,304,392 | |
Total | 330,514,535 | 281,003,457 | |